All Type of News
Over the pressure of the pharmaceutical industry to delay the Drug Price Reduction, the Ministry of Health and Welfare stated “as it is scheduled”
Over the argument of the pharmaceutical industry to defer the Drug Price Reduction followed by the Real Transaction Price Investigation, the Ministry of Health and Welfare has expressed negative opinions.
On the 14th...
The pharmaceutical industry requested for the 1-year delay of the drug price reduction worth of KRW 200 billion
In order to overcome financial difficulties of the pharmaceutical industry caused by the MERS crisis and have new drug development and global expansion according to plan, the Korea Pharmaceutical Manufacturers Associa...
10 mid-sized pharmaceutical companies are mentioned to be put on the market as loosing positions
Since uncertainty increases in the pharmaceutical environment, approximately 10 mid-sized pharmaceutical companies were known to be put on the market.
According to the pharmaceutical industry, positions of medium pha...
The Hanmi Pharm’s Amosartan will be printed by the kernel identification laser for the first time in KoreaThe new hypertension complex, ‘Amosartan,’ is adopted by the kernel identification printing method using the ultraviolet(UV) laser printer for the first time in Korea.
Hanmi Ph...
|
Active discussions regarding countermeasures of the MERS end
While the crisis of Middle East Respiratory Syndrome(MERS), which has swept the nation, is coming to an end, a place was prepared to discuss methods to prevent the second MERS which may occur in the future.
Using the...
Actavis, a foreign generic company, will enter the domestic market, followed after Teva and AlvogenAnother generic of a multinational brand is expected to enter the domestic market.
The company is the top U.S. generic company, Actavis. After taking over the pharmaceutical co...
|
“The current Drug Price System will be changed if decided to be remade”
A common opinion was formed that the conventional drug price deliberation system needs to be revised to make improvement of the domestic pharmaceutical industry, such R&D invigoration.
The Korea Pharmaceutical Manufa...
12 pharmaceutical companies exceeded KRW 1 trillion market capitalization while Hanmi Science recorded over KRW 7 trillion
Entry of the 1 Trillion Market Capitalization Club is no longer a surprising news in the pharmaceutical industry. The club used to be exclusively possessed by a part of the top companies, such as Yuhan Corporation and...
Daklinza troubled with the September launch of Sovaldi
It seems that a domestic approval of the hepatitis type C treatment, ‘Sovaldi(generic name: sofosbuvir),’ will be made between September and October. As the approval of Sovaldi has come closer, BMS Korea has also been...
The countdown to the domestic entry of an insulin decreasing the risk of hypoglycemia, pre-noticing a war of nerves
As the countdown has begun to the domestic launch of the next-generation basal insulin diabetes treatment having low risk of hypoglycemia, the markets concerned has shown high interests.
Recently, the Novo Nordisk’s ...

